TabletAnti HIV

Efavirenz Tablets

Efavirenz · Non-nucleoside reverse transcriptase inhibitor (NNRTI)

TabletAnti HIV

Efavirenz TabletsProspero Healthcare

Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) supplied as tablets. It is used in standard clinical practice for HIV-1 infection (combination antiretroviral therapy), as described in general pharmacological references.

Uses

HIV-1 infection (combination antiretroviral therapy)

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Efavirenz
Available strengthsIndicative: 600 mg
Dosage form: Tablet
Therapeutic category: Anti HIV Anti Viral Anti Hepatitis
Therapeutic class: Non-nucleoside reverse transcriptase inhibitor (NNRTI)
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category